home · filing · 0001213900-23-034007
8-K
filed April 28, 2023, 7:59 PM ET
ticker FRMM
CIK 0001690080
leadership
confidence high
sentiment neutral
materiality 0.50
180 Life Sciences removes Interim tag from CFO, increases executive salaries and awards back pay
FORUM MARKETS Inc
Ozan Pamir named CFO (Interim title removed); salary increased to $380,000 and target bonus to 40% effective April 1, 2023.
Third amendments to employment agreements with CEO, CFO, and CSO raise salaries by 3.5% effective January 1, 2023.
Board approved back pay of $111,675 to CEO James Woody; $24,154 to CFO Ozan Pamir; $50,343 to CSO Jonathan Rothbard.
Board awarded 2021 cash bonuses: CEO Woody $50,000; CFO Pamir $22,500 (in addition to $30,000 already paid); CSO Rothbard $10,000.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Role change
Ozan Pamir
Chief Financial Officer
Effective 2023-04-27
Filed April 28, 2023, 7:59 PM ET
removed the ‘Interim’ title of Ozan Pamir, the Chief Financial Officer of the Company.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ozan Pamir changed role as Chief Financial Officer at FORUM MARKETS Inc.
Action removed interim title
Role Chief Financial Officer
Exact text from the filing
removed the ‘Interim’ title of Ozan Pamir, the Chief Financial Officer of the Company.
View on SEC.gov
Source: SEC EDGAR
accession 0001213900-23-034007
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.